![]() |
Name |
Penicibrocazine C
|
Molecular Formula | C20H26N2O6S2 | |
IUPAC Name* |
(1R,4S,5S,8S,9S,11R,14S,15S,18S,19S)-5,8,15,18-tetrahydroxy-1,11-bis(methylsulfanyl)-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-6,16-diene-2,12-dione
|
|
SMILES |
CS[C@@]12C[C@@H]3[C@H](C=C[C@@H]([C@H]3N1C(=O)[C@@]4(C[C@@H]5[C@H](C=C[C@@H]([C@H]5N4C2=O)O)O)SC)O)O
|
|
InChI |
InChI=1S/C20H26N2O6S2/c1-29-19-7-9-11(23)3-5-13(25)15(9)21(19)18(28)20(30-2)8-10-12(24)4-6-14(26)16(10)22(20)17(19)27/h3-6,9-16,23-26H,7-8H2,1-2H3/t9-,10-,11+,12+,13+,14+,15+,16+,19-,20-/m1/s1
|
|
InChIKey |
CVUVUDMOCUORTF-OTLVIJGASA-N
|
|
Synonyms |
Penicibrocazine C
|
|
CAS | NA | |
PubChem CID | 139583112 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 454.6 | ALogp: | -1.0 |
HBD: | 4 | HBA: | 8 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 172.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 30 | QED Weighted: | 0.417 |
Caco-2 Permeability: | -5.852 | MDCK Permeability: | 0.00001040 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.066 |
Human Intestinal Absorption (HIA): | 0.042 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.078 | Plasma Protein Binding (PPB): | 77.64% |
Volume Distribution (VD): | 0.452 | Fu: | 34.62% |
CYP1A2-inhibitor: | 0.007 | CYP1A2-substrate: | 0.1 |
CYP2C19-inhibitor: | 0.019 | CYP2C19-substrate: | 0.854 |
CYP2C9-inhibitor: | 0.255 | CYP2C9-substrate: | 0.066 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.043 |
CYP3A4-inhibitor: | 0.308 | CYP3A4-substrate: | 0.976 |
Clearance (CL): | 5.674 | Half-life (T1/2): | 0.792 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.021 |
Drug-inuced Liver Injury (DILI): | 0.987 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.02 | Maximum Recommended Daily Dose: | 0.028 |
Skin Sensitization: | 0.178 | Carcinogencity: | 0.929 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.005 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003596 | ![]() |
0.477 | D03IKT | ![]() |
0.198 | ||
ENC004752 | ![]() |
0.423 | D08PIQ | ![]() |
0.192 | ||
ENC002661 | ![]() |
0.414 | D0V9DZ | ![]() |
0.192 | ||
ENC003671 | ![]() |
0.414 | D0F1EX | ![]() |
0.189 | ||
ENC003809 | ![]() |
0.333 | D03BLF | ![]() |
0.189 | ||
ENC000993 | ![]() |
0.309 | D0D1SG | ![]() |
0.186 | ||
ENC006009 | ![]() |
0.287 | D02FEM | ![]() |
0.184 | ||
ENC005509 | ![]() |
0.287 | D0WE3O | ![]() |
0.183 | ||
ENC003617 | ![]() |
0.287 | D00GOS | ![]() |
0.180 | ||
ENC003549 | ![]() |
0.287 | D03DIG | ![]() |
0.179 |